[{"Assets_0_FY_USD":6973466000.0,"NetIncomeLoss_1_FY_USD":253115000.0,"NetIncomeLoss_4_FY_USD":895522000.0,"StockholdersEquity_0_FY_USD":4449245000.0,"EarningsPerShareBasic_1_FY_USD":2.41,"EarningsPerShareBasic_4_FY_USD":8.55,"EarningsPerShareDiluted_1_FY_USD":2.19,"EarningsPerShareDiluted_4_FY_USD":7.7,"NetCashProvidedByUsedInOperatingActivities_4_FY_USD":1473396000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_4_FY_shares":116367000.0,"WeightedAverageNumberOfSharesOutstandingBasic_4_FY_shares":104719000.0,"Ticker":"REGN","CIK":"872589","name":"REGENERON PHARMACEUTICALS INC","OfficialName":"Regeneron Pharmaceuticals Inc. Common Stock","form":"10-K","period":"20161231","fy":"2016.0","fp":"FY","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"77738004554.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"SP500","filed":"20170209"}]